Executive Committee: argenx SE

Manager
Positions heldSince
Tim van Hauwermeiren

Tim van Hauwermeiren

54 year

Chief Executive Officer 14/07/2008
Founder 31/12/2007
Luc Truyen

Luc Truyen

61 year

Chief Tech/Sci/R&D Officer 31/03/2022
Filip Borgions

Filip Borgions

Chief Tech/Sci/R&D Officer 31/12/2014
Karen Massey

Karen Massey

47 year

Chief Operating Officer 12/03/2023
Peter Ulrichts

Peter Ulrichts

46 year

Chief Tech/Sci/R&D Officer 31/12/2022
Hemamalini Moorthy

Hemamalini Moorthy

56 year

General Counsel 13/02/2022
Karl Gubitz

Karl Gubitz

56 year

Director of Finance/CFO 31/05/2021
Marc Schorpion

Marc Schorpion

68 year

Human Resources Officer 30/11/2018
Beth Delgiacco

Beth Delgiacco

Investor Relations Contact 31/12/2017
Public Communications Contact 31/12/2017

Composition of the Board of Directors: argenx SE

Director
CommitteesSince
Peter K. M. Verhaeghe

Peter K. M. Verhaeghe

68 year

Audit Committee 23/07/2015
Compensation Committee 23/07/2015
Nominating Committee 23/07/2015
James Daly

James Daly

64 year

Audit Committee 26/06/2019
Compensation Committee 09/06/2016
Governance Committee 26/06/2019
Nominating Committee 26/06/2019
Ana Cespedes

Ana Cespedes

53 year

Compensation Committee 11/12/2022
Nominating Committee 11/12/2022
Executive Committee 28/02/2025
Joseph deBethizy

Joseph deBethizy

76 year

Compensation Committee Chair 12/05/2015
Nominating Committee Chair 12/05/2015
Anthony Adam Rosenberg

Anthony Adam Rosenberg

72 year

Audit Committee 31/03/2020
Compensation Committee Chair
Steve Krognes

Steve Krognes

57 year

Audit Committee 02/06/2025
Audit Committee Chair 12/06/2024
Tim van Hauwermeiren

Tim van Hauwermeiren

54 year

Governance Committee
Nominating Committee
Brian Kotzin

Brian Kotzin

76 year

Compensation Committee Chair 31/05/2019
Camilla Sylvest

Camilla Sylvest

54 year

Director/Board Member 07/09/2022
Independent Dir/Board Member 07/09/2022
Pamela Klein

Pamela Klein

65 year

Director/Board Member 27/04/2016
Independent Dir/Board Member 27/04/2016

Former Officers and Directors: argenx SE

Insider
Positions held
SinceUntil
Robert Woods
Robert Woods
Corporate Officer/Principal 04/04/2018 31/05/2023
Kelsey Kirk
Kelsey Kirk
Public Communications Contact - 28/02/2023
Werner Lanthaler
Werner Lanthaler
Director/Board Member 31/03/2014 26/02/2023
Independent Dir/Board Member 31/03/2014 26/02/2023
Wim Parys
Wim Parys
Chief Tech/Sci/R&D Officer 30/06/2019 30/03/2022
Yvonne Greenstreet
Yvonne Greenstreet
Director/Board Member 10/05/2021 02/03/2022
Dirk Beeusaert
Dirk Beeusaert
General Counsel 31/03/2017 02/03/2022
Eric Castaldi
Eric Castaldi
Comptroller/Controller/Auditor 25/04/2017 -
Director/Board Member 31/03/2014 25/04/2017
Director of Finance/CFO 31/03/2014 31/05/2021
David Lacey
David Lacey
Director/Board Member 08/07/2014 10/05/2021
Independent Dir/Board Member 08/07/2014 10/05/2021
Nicolas Leupin
Nicolas Leupin
Chief Tech/Sci/R&D Officer 31/01/2016 30/06/2019
John Paul de Koning
John Paul de Koning
Director/Board Member 31/12/2008 25/04/2017
Harrold van Barlingen
Harrold van Barlingen
Director/Board Member 31/12/2007 12/05/2015
Bruno Montanari
Bruno Montanari
Director/Board Member 31/12/2007 12/05/2015
Michael Bart Sheffery
Michael Bart Sheffery
Director/Board Member 08/07/2014 -
Alain Thibault
Alain Thibault
Chief Tech/Sci/R&D Officer 18/03/2012 -
Johan Cardoen
Johan Cardoen
Director/Board Member 31/12/2007 01/01/2011
Debbie Allen
Debbie Allen
Corporate Officer/Principal 31/10/2010 -
Torsten Dreier
Torsten Dreier
Founder 31/12/2007 -
Corporate Officer/Principal 30/04/2008 -
Hans J. W. de Haard
Hans J. W. de Haard
Chief Tech/Sci/R&D Officer 30/06/2008 -
Founder 31/12/2007 -
Jacobus C. Rasser
Jacobus C. Rasser
General Counsel - -
Christina Takke
Christina Takke
Director/Board Member - -
Joke Comijn
Joke Comijn
Public Communications Contact - -
Rebecca Rupert
Rebecca Rupert
Sales & Marketing - -
David Crist
David Crist
Corporate Officer/Principal - -
Linda Lebon
Linda Lebon
General Counsel - -

Age distribution of managers

Parity Men Women

Male16
Female4

Of which Executive Committee

Male6
Female3

Of which Directors

Male9
Female1

Revisions

Recommandations analystes
-
Évolution recommandations analystes 1 an
-
Évolution recommandations analystes 4 mois
-
Objectif analystes
-
Évolution objectif analystes 1 an
-
Évolution objectif analystes 4 mois
-
ESG MSCI

ESG MSCI

Environnement
Social
Gouvernance
Polémique
Controverses Ethiques
No
Controverses sur les droits de l'Homme
No
Controverses Subventions fiscales
No
Conforme à la finance Islamique
No
Logo argenx SE
argenx SE is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx SE aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx SE developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises.
Employees
1,599
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW